Seeking Alpha

Raptor Pharma making CEO change

  • Christopher Starr, Raptor Pharma's (RPTP) CEO since 2006, will be retiring at year's end. COO Julie Anne Smith will replace him.
  • Starr will remain on Raptor's board following his resignation as CEO, and will conitnue to "consult on Raptor development projects."
  • Smith has been Raptor's COO since Sep. '12. Prior to joining Raptor, she was the sales chief for Enobia Pharma.
From other sites
Comments (1)
  • joelkatz
    , contributor
    Comments (507) | Send Message
    This change is welcomed
    7 Jul 2014, 07:15 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs